Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Create data set
研究概览
简要总结
The Carevive registry collects patient characteristics, patient symptoms, and treatment experience data from patients receiving cancer treatment for breast, lung, GI or multiple myeloma. For this study, a core set of variables is collected on each patient in the Carevive platform. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic Patient Reported Outcome surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All participants must be 18 years of age or older.
- •Subjects may be any stage and anywhere in the treatment continuum.
- •Subject participants must have a diagnosis of breast, lung, GI or ovarian cancer or multiple myeloma.
- •Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
- •All participants must be able to understand English.
排除标准
- •Any patient who cannot understand written or spoken English.
- •Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
- •Any patient on a treatment clinical trial.
- •Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
结局指标
主要结局
Create data set
时间窗: 12 weeks
Project outcome measures for this project are the prevalence, frequency, and severity of symptoms in each disease group, longitudinal change in symptom experience, and time on treatment from enrollment to next treatment.
次要结局
未报告次要终点